Bayer starts Phase III trial on regorafenib in liver cancer

German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug regorafenib in patients with advanced liver cancer.

_0">

The drug, also known as Stivarga, will be tested in the third and last phase of trials required for marketing approval on patients with inoperable hepatocellular carcinoma (HCC) that has worsened despite prior treatment with Bayer's Nexavar drug. (Reporting by Ludwig Burger)

Popular posts from this blog

'I was his Christian Grey fantasy.' Ex-girlfriend Paige Lorenze says Armie Hammer carved an A into her groin area as she warns 'narcissistic' actor could 'seriously injure another woman' with his BDSM obsession

Model Stella Tennant dies 'suddenly' aged 50 as her family pay tribute to 'wonderful woman and an inspiration to us all'

Teenage boy, 15, charged after allegedly having sex with two 12-year-old girls and recording the encounter on his phone - but he's still allowed to go to school with them while on bail